| Articles |
Informed Consent in Right-to-Try – A Dubious Assumption
|
| By Rebecca Dresser | Read PDF | 11 Wake Forest J.L. & Pol’y 1 |
| | | |
| The Stories We Tell: Narrative, Policymaking, and the Right to Try |
| By Professor Christine Nero Coughlin & Professor Nancy M.P. King | Read PDF | 11 Wake Forest J.L. & Pol’y 17 |
| | | |
| Three Framings of “Faster” at the FDA and the Federal Right to Try |
| By Jordan Paradise, J.D. | Read PDF | 11 Wake Forest J.L. & Pol’y 53 |
| | | |
| Paying for Unapproved Medical Products |
| By Kelly McBride Folkers, Alison Bateman-House, & Christopher Robertson | Read PDF | 11 Wake Forest J.L. & Pol’y 85 |
| | | |
| Recent Legislation That Secured A “Right to Try” Unapproved Drugs: Why The “Fuss” Over A “Fix” Of What “Ain’t Broke”? |
| By William M. Zoffer, J.D. | Read PDF | 11 Wake Forest J.L. & Pol’y 119 |
| | | |
| Setting the Stage: Fifty Years of U.S. End-of-Life Care Debates |
| By John C. Moskop | Read PDF | 11 Wake Forest J.L. & Pol’y 203 |
| | | |
| Making Odds – Ethical and Pedagogical Imperatives of Building A Performable Case Study (PCS) |
| By Richard Robeson | Read PDF | 11 Wake Forest J.L. & Pol’y 225 |
| | | |
